Jeffrey Packman
Corporate Officer/Principal bei CLEMENTIA PHARMACEUTICALS INC
Ursprung des Netzwerks ersten Grades von Jeffrey Packman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jeffrey Packman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
| IBEX TECHNOLOGIES | Medical Specialties | Founder | |
| KANE BIOTECH INC. | Miscellaneous Commercial Services | Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VisionGate, Inc.
 VisionGate, Inc. Medical SpecialtiesHealth Technology VisionGate, Inc. provides in-vitro automated 3D cell structure and analysis solutions. It focuses on early detection and prevention of lung cancer. The firm’s attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. The company was founded by Alan C. Nelson and is headquartered in Phoenix, AZ. | Medical Specialties | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
Sectoral Asset Management, Inc.
 Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral Asset Management, Inc. (Sectoral) is an investment management firm headquartered in Montréal, Canada. The firm was founded in 2000 by Jérôme G. Pfund and Michael J. Sjöström. They are a wholly-owned subsidiary of Sectoral Asset Management Holding Ltd. in Hong Kong. Sectoral manages public and private equity healthcare strategies for investors around the world. Their clients include sovereign wealth funds, private banks, and family offices. In addition, they have long-standing sub-advisory relationships with institutional investors in Europe and Asia. | Investment Managers | Corporate Officer/Principal | |
| McGill University | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Concordia University | College/University | Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
| University of Toronto | College/University | Undergraduate Degree | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| HEC Montréal | College/University | Masters Business Admin Undergraduate Degree | |
| THALLION PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| Canadian Genetic Disease Network | Director/Board Member | ||
| Industrial Biotechnology Association of Canada | Director/Board Member | ||
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal Director of Finance/CFO | ||
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Chairman | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Chairman | |
| PROFOUND MEDICAL CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
Searchlight Pharma, Inc.
 Searchlight Pharma, Inc. Pharmaceuticals: MajorHealth Technology Searchlight Pharma, Inc. operates as a specialty healthcare company. It acquires and develops long life health care products. The company was founded in 2015 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
Zingenix Ltd.
 Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Biotechnology | Chief Executive Officer | |
Thinking Capital Financial Corp.
 Thinking Capital Financial Corp. Finance/Rental/LeasingFinance Thinking Capital Financial Corp. operates as a financial technology company that provides financing to small and medium-sized enterprises. Its products include Fixed Payment Solution, Flexible Payment Solution, Common Financing Needs and Small Business Benefits. The company was founded by Jeff Mitelman and Peter Mazoff in 2006 and is headquartered in Montreal, Canada. | Finance/Rental/Leasing | Director of Finance/CFO | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
8569975 Canada, Inc.
 8569975 Canada, Inc. Miscellaneous Commercial ServicesCommercial Services 8569975 Canada, Inc. provides other services. The private company is based in Dollard Des Ormeaux, Canada. | Miscellaneous Commercial Services | President | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
Bicycle Therapeutics, Inc.
 Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Pharmaceuticals: Major | Chairman | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chairman | |
Interfonction Ltd.
 Interfonction Ltd. Building ProductsProducer Manufacturing Part of Interfonction Ltd., Interfonction is a Canadian company that manufactures aluminum and glass interior doors. The company is based in Sherbrooke, Canada. The company was founded in 1990 by Pierre Legault. The CEO is Johanne Tousignant. Interfonction was acquired by Interfonction /Private Group/ on December 31, 2014. | Building Products | Founder |
Statistik
International
| Kanada | 24 |
| Vereinigte Staaten | 23 |
| Israel | 3 |
| Frankreich | 3 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Operativ
| Director/Board Member | 151 |
| Independent Dir/Board Member | 62 |
| Corporate Officer/Principal | 45 |
| Chairman | 38 |
| Chief Executive Officer | 21 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Mott | 45 |
| Pierre Legault | 45 |
| Francois Nader | 28 |
| David Bonita | 27 |
| Jean-François Pariseau | 24 |
| Shawn Tomasello | 22 |
| Robert A. Heft | 18 |
| Michael Singer | 16 |
| Joseph Walewicz | 15 |
| Donna Grogan | 12 |
| Clarissa Desjardins | 12 |
| James M. Roach | 11 |
| Allan Mandelzys | 10 |
| Eric Grinstead | 9 |
| Steve Forte | 7 |
- Börse
- Insiders
- Jeffrey Packman
- Unternehmensverbindungen
